Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…
The post New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA…
New patent expiration for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Annual Drug Patent Expirations for CYTALUX Cytalux is a drug marketed by On Target Labs and is included in one NDA. The generic ingredient in CYTALUX is pafolacianine sodium. Additional…
The post New patent for On Target drug CYTALUX appeared first on …
ABILIFY MAINTENA KIT (aripiprazole) Otsuka pharm co ltd Patent: 9,089,567 Expiration: Jan 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Patent Expirations for the …
Drug Patent Expirations for the Week of January 23, 2022 Read Post »
Annual Drug Patent Expirations for BIJUVA Bijuva is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Therapeuticsmd Inc drug BIJUVA appeared first o…
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
New patent expiration for Allergan drug ALPHAGAN P Read Post »
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Otsuka drug REXULTI appeared first on DrugPatentWat…
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pa…
Which pharmaceutical companies have the most drug patents in Australia? Read Post »
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Sun Pharm drug WINLEVI appeared first on DrugPatentWatch …
Annual Drug Patent Expirations for GIAPREZA Giapreza is a drug marketed by La Jolla Pharma and is included in one NDA. It is available from one supplier. There are nine…
The post New patent for La Jolla drug GIAPREZA appeared first on DrugPatentWatch -…
Get new actionable insights and updates from BiotechBlog
